Wines and grape juices as modulators of platelet aggregation in healthy human subjects

Clinica Chimica Acta

Volumn 246, Issue 1-2, 1996, Pages 163-182

  Pace Asciak, Cecil R ^a   Rounova, Olga ^a   Hahn, Susan E ^b   Diamandis, Eleftherios P ^b   Goldberg, David M ^b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alcohol; Arachidonate metabolism; Atherosclerosis; Coronary heart disease; Cyclo oxygenase; Eicosanoid production; Grape juice; Lipoxygenase; Platelet aggregation; Thromboxane B2; Wine

Indexed keywords

RESVERATROL; THROMBOXANE B2;

ADULT; BLOOD ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FRUIT JUICE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; WINE;

EID: 0029867396     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06236-5     Document Type: Conference Paper

References (58)

1. Rimm EB, Giovannucci EL, Willett WC et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;339:464-468.
2. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med 1992;117:646-654.
3. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. Br Med J 1994;309:911-918.
4. Suh I, Shaten J, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. Ann Intern Med 1992;116:881-887.
5. Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol-intake, increased levels of high-density lipoprotein and its subfractions and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-1834.
6. Fenn CG, Littleton JM. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition. Thromb Haemostas 1982;48:49-53.
7. Rubin R, Rand ML. Alcohol and platelet function. Alcohol Clin Exp Res 1994;18:105-110.
8. Renaud SC, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly prospective heart disease study. Am J Clin Nutr 1992;55:1012-1017.
9. St. Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;1:1017-1020.
10. Hegsted DM, Ausman LM. Diet, alcohol and coronary heart disease in men. J Nutr 1988;118:1184-1189.
11. Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-1526.
12. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994;344:1719-1723.
13. Singleton V. Grape and wine phenolics; background and prospects. In: Singleton VL, ed. Proceedings of the Symposium: Grape and Wine Centennial, 1980. Davis, CA: University of California Press, 1982;215-227.
14. Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992;43:49-52.
15. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-457.
16. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993;341:1103-1104.
17. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet 1994;344:193-194.
18. Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 1995;41:32-35.
19. Steinberg D, Parsatharathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
20. Witztum J. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-795.
21. Kimura Y, Okuda H, Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 1985;834:275-278.
22. Chung M-I, Teng C-M, Cheng K-L, Ko F-N, Lin C-N. An antiplatelet principle of Veratrum formosanum. Planta Med 1992;58:274-276.
23. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995;236:207-219.
24. Seigneur M, Bonnet J, Dorian B et al. Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids. J Appl Cardiol 1990;5:215-222.
25. Goldberg DM, Yan J, Ng E et al. Direct injection gas chromatographic mass spectrometric assay for trans-resveratrol. Anal Chem 1994;66:3959-3963.
26. Goldberg DM, Yan J, Ng E et al. A global survey of trans-resveratrol concentrations in commercial wines. Am J Enol Vitic 1995;46:159-165.
27. Pace-Asciak CR. Profiling of prostaglandins and related products by GC/MS with negative-ion chemical-ionization detection. In: Hayaishi O, Yamamoto S, eds. Advances in prostaglandin, thromboxane and leukotriene research. Raven Press, New York, 1985;39-43.
28. Rand ML, Packham MA, Kinlough-Rathbone RL, Mustard JF. Effects of ethanol on pathways of platelet aggregation in vitro. Thromb Haemostas 1988;59:383-387.
29. Rubin R. Ethanol interferes with collagen-induced platelet activation by inhibition of arachidonic acid mobilization. Arch Biochem Biophys 1989;270:99-113.
30. Keller JW, Folts JD. Combined inhibitory effects of aspirin and ethanol on adrenaline exacerbation of acute platelet thrombus formation in stenosed canine coronary arteries. Cardiovasc Res 1990;24:191-197.
31. 2. Lipids 1992;27:255-260.
32. Rubin R, Ponnappa BC, Thomas AP, Hoek JB. Ethanol stimulates shape change in human platelets by activation of phosphoinositide-specific phospholipase C. Arch Biochem Biophys 1988;260:480-492.
33. Rubin R, Hoek JB. Alcohol-induced stimulation of phospholipase C in human platelets requires G-protein activation. Biochem J 1988;254:147-153.
34. Rand ML, Vickers JD, Kinlough-Rathbone RL, Packham MA, Mustard JF. Thrombin induced inositol trisphosphate production by rabbit platelets is inhibited by ethanol. Biochem J 1988;251:279-284.
35. Benistant C, Rubin R. Ethanol inhibits thrombin-induced secretion by human platelets at a site distinct from phospholipase C or protein kinase C. Biochem J 1990;269:489-497.
36. 2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents. Thromb Haemostas 1989;62:968-976.
37. Davis JW, Phillips PE. The effect of ethanol on human platelet aggregation in vitro. Atherosclerosis 1970;11:473-477.
38. Haut MJ, Cowan DH. The effect of ethanol on hemostatic properties of human blood platelets. Am J Med 1974;56:22-33.
39. Fenn CG, Littleton JM. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition. Thromb Haemostas 1982;48:49-53.
40. 2) synthesis, platelet aggregation, and platelet thromboxane release. Br Med J 1983;287:1495-498.
41. 2 production but has no effect on lung prostacyclin synthesis in humans. Thromb Res 1983;33:1-8.
42. Kontula K, Viinikka L, Ylikorkala O, Ylikahri R. Effect of acute ethanol intake on thromboxane and prostacyclin in human. Life Sci 1982;31:261-264.
43. Walzem RL, Teissedre P-L, German JB, Hansen, RJ, Frankel EN, Waterhouse AL. Absorption of the antioxidant catechin from red wine. Clin Chem 1996; in press.
44. Veenstra J, Kluft C, Ockhuizen T, Pol H v.d., Wedel M, Schaafsma G. Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor. Thromb Haemostas 1990;63:345-348.
45. Hutton RA, Fink R, Wilson DT, Marjot DH. Platelet hyperaggregability during alcohol withdrawal. Clin Lab Haematol 1981;3:223-229.
46. Ruf J-C, Berger J-L, Renaud S. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation. Arterioscler Thromb Vasc Biol 1995;15:140-144.
47. McGregor L, Renaud S. Inhibitory effect of alcohol on platelet functions of rats fed saturated fats. Thromb Res 1981;22:221-225.
48. Fenn CG, Littleton JM. Interactions between ethanol and dietary fat in determining human platelet function. Thromb Haemostas 1984;51:50-53.
49. Renaud S, Morazain R, Godsey F et al. Nutrients, platelet function and composition in nine groups of French and British farmers. Atherosclerosis 1986;60:37-48.
50. 2-independent platelet responses. Arterioscler Thromb 1994; 14:1372-1377.
51. 2 formation. Arterioscler Thromb 1994;14:1379-1385.
52. Goldberg DM, Halhn SE, Parkes JG. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 1995;1995;237:155-187.
53. Klurfeld DM, Kritchevsky D. Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits. Exp Mol Pathol 1981;34:62-71.
54. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of polygonum cuspidatum Sieb et Zucc. on lipid metabolism. Chem Pharm Bull 1982;30:1766-1779.
55. Yugarani T, Tan BKH, Teh M, Das NP. Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 1992;27:181-186.
56. Tebib K, Bitri L, Besancon P, Rouanet J-M. Polymeric grape seed tannins prevent plasma cholesterol changes in high-cholesterol-fed rats. Food Chem 1994;49:403-406.
57. Gronbaek M, Deis A, Sorensen TIA, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J 1995;310:1165-1169.
58. Klatsky AL, Armstrong MA. Alcoholic beverage choice and risk of coronary artery disease mortality: do red wine drinkers fare best? Am J Cardiol 1993;71:467-469.